Stellantis (STLA) confirmed that its CEO Carlos Tavares will retire in early 2026 at the end of his contract. Read more ...
A Bluebird Bio gene therapy has helped children with a devastating neurological disorder, but seven have developed blood ...
Seven out of 67 children who were given bluebird's (BLUE) gene therapy Skysona during clinical trials ended up developing ...
The FDA has approved Roche’s inavolisib plus Pfizer's Ibrance and fulvestrant in a subtype of breast cancer over a month ...
Seven young boys treated with bluebird bio’s gene therapy for a rare neurological disease have been diagnosed with blood ...
Whilst the events do not outline any new safety risks, the data gives a new understanding of the link between oncogenesis and ...
Pfizer shared that the combination of its drugs Talzenna and Xtandi extended survival in men with metastatic ...
Seven young boys given Bluebird's Skysona later developed blood cancers, findings that could shape how doctors balance the gene therapy’s risks against its benefit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback